Pancreatic Cancer Research

ResearcherKunming Institute of ZoologyActive in the last 2 years

Ren Lai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3123-2336; OpenAlex author ID A5010238428. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. Correction: Targeting surface nucleolin induces autophagy-dependent cell death in pancreatic cancer via AMPK activation. Last author DOI 10.1038/s41388-026-04005-2↗
  2. Targeting surface nucleolin induces autophagy-dependent cell death in pancreatic cancer via AMPK activation. Last author DOI 10.1038/s41388-018-0556-x↗
  3. CDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition to CDKN2A. Co-author DOI 10.1038/onc.2017.316↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qiu Tu · 3 shared papers, 2018–2026 · strength 0.45
  2. Cheng Xu · 1 shared paper, 2026 · strength 0.29
  3. Xudong Zhao · 2 shared papers, 2018–2019 · strength 0.16
  4. Cheng Xu · 1 shared paper, 2019 · strength 0.09
  5. Dejun Yang · 1 shared paper, 2018 · strength 0.07
  6. Bin Sun · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.